Aldeyra Claims Success In Final Phase III For First-In-Class Dry Eye Drug

Both Co-Primary Endpoints Hit In TRANQUILITY-2

 
• By Jessica Merrill
  
eye dropper
Aldeyra is developing a new eye drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D